Is the prognosis of non‐hypertensive, COVID‐19 patients treated with renin–angiotensin–aldosterone system inhibitors more uncertain?

Previous studies suggested that ongoing treatment with renin–angiotensin–aldosterone system (RAAS) inhibitor drugs may alter the course of SARS‐CoV‐2 infection and promote the development of more severe forms of the disease. The authors conducted a comparative, observational study to retrospectively...

Descripción completa

Detalles Bibliográficos
Autores principales: García Martínez, Juan José, Wozniak, Hannah, Salamin, Pauline, Giraud, Raphaël, Le Terrier, Christophe, Bendjelid, Karim
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
ORIGINAL ARTICLES
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9672383/
https://www.ncbi.nlm.nih.gov/pubmed/36397298
http://dx.doi.org/10.14814/phy2.15512

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9672383/
https://www.ncbi.nlm.nih.gov/pubmed/36397298
http://dx.doi.org/10.14814/phy2.15512

Ejemplares similares